Arber, D.A. & Hasserjian, R.P. (2015) Reclassifying myelodysplastic syndromes: what’s where in the new WHO and why. Hematology/the Education Program of the American Society of Hematology, 2015, 294–298. Cui, R.,… Click to show full abstract
Arber, D.A. & Hasserjian, R.P. (2015) Reclassifying myelodysplastic syndromes: what’s where in the new WHO and why. Hematology/the Education Program of the American Society of Hematology, 2015, 294–298. Cui, R., Gale, R.P., Xu, Z., Qin, T., Fang, L., Zhang, H., Pan, L., Zhang, Y. & Xiao, Z. (2012) Clinical importance of SF3B1 mutations in Chinese with myelodysplastic syndromes with ring sideroblasts. Leukemia Research, 36, 1428–1433. Greenberg, P.L., Tuenchler, H., Schanz, J., Sanz, G., Garcia-Manero, G., Sol e, F., Bennett, J.M., Bowen, D., Fenaux, P. & Dreyfus, F. (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood, 120, 2454–2465. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W. (2001) Pathology and genetics of tumours of the haematopoietic and lymphoid tissues. IARC Press, France. Malcovati, L., Karimi, M., Papaemmanuil, E., Ambaglio, I., Jadersten, M., Jansson, M., Elena, C., Galli, A., Walldin, G., Della Porta, M.G., Raaschou-Jensen, K., Travaglino, E., Kallenbach, K., Pietra, D., Ljungstrom, V., Conte, S., Boveri, E., Invernizzi, R., Rosenquist, R., Campbell, P.J., Cazzola, M. & Hellstrom Lindberg, E. (2015) SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood, 126, 233–241. Mufti, G.J., Bennett, J.M., Goasguen, J., Bain, B.J., Baumann, I., Brunning, R., Cazzola, M., Fenaux, P., Germing, U., Hellstr€ om-Lindberg, E., Jinnai, I., Manabe, A., Matsuda, A., Niemeyer, C.M., Sanz, G., Tomonaga, M., Vallespi, T. & Yoshimi, A.; International Working Group on Morphology of Myelodysplastic Syndrome.(2008) Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica,93,1712–1717. Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J.S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., Godfrey, A.L., Rapado, I., Cvejic, A., Rance, R., McGee, C., Ellis, P., Mudie, L.J., Stephens, P.J., McLaren, S., Massie, C.E., Tarpey, P.S., Varela, I., Nik-Zainal, S., Davies, H.R., Shlien, A., Jones, D., Raine, K., Hinton, J., Butler, A.P., Teague, J.W., Baxter, E.J., Score, J., Galli, A., Della Porta, M.G., Travaglino, E., Groves, M., Tauro, S., Munshi, N.C., Anderson, K.C., El-Naggar, A., Fischer, A., Mustonen, V., Warren, A.J., Cross, N.C., Green, A.R., Futreal, P.A., Stratton, M.R. & Campbell, P.J. (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. New England Journal of Medicine, 365, 1384–1395. Swerdllow, S., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, France.
               
Click one of the above tabs to view related content.